Oceania Healthcare Ltd (OCA)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.540 |
|---|---|
| 52-week range | 0.520 – 0.820 |
| Return, 1 month / 3 months | +2.9% / −11.5% |
| Return, 1 year / 3 years | −11.5% / −16.3% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 43.9% |
| Worst drawdown (1 year) | -36.6% |
| Average daily value traded | 0.01M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Oceania Healthcare is a New Zealand provider of retirement village living and aged care services. The company runs retirement villages that offer independent living units and apartments, together with care facilities providing rest home care, hospital-level care and dementia care. Its residents are older people seeking supported living and continuing care, and its operations are concentrated in communities across New Zealand, with the company based in that country.
The shares are listed on the Australian Securities Exchange in Australia under the code OCA, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Oceania Healthcare Ltd (OCA) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.540 on 19 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 808 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.5% and over the last three months it fell 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -14.0% | ||
| From 52-week high | -34.1% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -11.5% | ||
| 6-month return | -6.1% | ||
| 12-month return, skipping the last month | -13.9% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.6% | ||
| Liquidity | 22 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M AUD | ||
| Zero-volume days | 46.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +2.9% |
| 3 months | −11.5% |
| 6 months | −6.1% |
| 1 year | −11.5% |
| 3 years | −16.3% |
| 5 years | −57.3% |
Signals
| 50-day / 200-day average | 0.606 / 0.628 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.007 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jun 2023 | NZD 0.0104 |
| 5 Dec 2022 | NZD 0.0190 |
| 6 Jun 2022 | NZD 0.0177 |
| 3 Dec 2021 | NZD 0.0171 |
| 7 Jun 2021 | NZD 0.0165 |
| 9 Feb 2021 | NZD 0.0103 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.